Alignment Healthcare LLC (ALHC)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Alignment Healthcare LLC.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 11 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
Uses AIAlignment Healthcare setzt KI laut eigenen SEC-Berichten operativ in der firmeneigenen Technologieplattform AVA ein: Maschinelles Lernen und künstliche Intelligenz prognostizieren Krankenhaus-Einweisungen, Wiedereinweisungsrisiken, Mitglieder-Zufriedenheit und Kündigungsrisiken, um die Versorgung der Medicare-Advantage-Mitglieder zu steuern. KI ist damit ein internes Werkzeug zur Kostensteuerung und Versorgungskoordination, aber keine eigene Umsatzquelle - das Unternehmen verkauft Krankenversicherung, keine KI-Produkte. Die Risikofaktoren nennen den eigenen KI-Einsatz zudem ausdrücklich als operatives, regulatorisches und rechtliches Risiko, was den Befund „nutzt“ (statt „verkauft“ oder „bedroht“) stützt.
View the full file — quotes, sources, reviewed filings
„Our internal care teams and external providers use AVA, our proprietary technology platform, to coordinate high-quality care for members and manage the complexity of the healthcare system."
Unsere internen Versorgungsteams und externen Leistungserbringer nutzen AVA, unsere firmeneigene Technologieplattform, um eine hochwertige Versorgung der Mitglieder zu koordinieren und die Komplexität des Gesundheitssystems zu bewältigen.
„It also uses machine learning and artificial intelligence to help predict various scenarios such as hospital admission and re-admission risk, member satisfaction, disenrollment risk and various disease propensity scores and how to best intervene."
Sie [die AVA-Plattform] nutzt zudem maschinelles Lernen und künstliche Intelligenz, um verschiedene Szenarien vorherzusagen - etwa das Risiko von Krankenhaus-Einweisungen und Wiedereinweisungen, die Mitglieder-Zufriedenheit, das Kündigungsrisiko und diverse Krankheits-Wahrscheinlichkeitswerte - sowie um zu bestimmen, wie am besten einzugreifen ist.
„Our use of machine learning and artificial intelligence, including within our AVA platform, may introduce operational, regulatory and legal risks that could adversely affect our business, financial condition and results of operations."
Unser Einsatz von maschinellem Lernen und künstlicher Intelligenz, auch innerhalb unserer AVA-Plattform, kann operative, regulatorische und rechtliche Risiken mit sich bringen, die unser Geschäft, unsere Finanzlage und unsere Geschäftsergebnisse beeinträchtigen könnten.
Filings Reviewed: 10-Q 2026-04-30 · 10-Q 2025-10-30 · 10-Q 2025-07-30 · 10-Q 2025-05-01 · 10-K 2026-02-27 · 10-K 2025-02-27
Rated on July 10, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 67.2% above the current price.
- Consensus
- Strong Buy
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.16 | – | 701 | 50.70 | -4.40 | -9 | -18 |
| 2025: Q1 | -0.05 | – | 927 | 47.50 | -1.00 | 17 | 8 |
| 2025: Q2 | 0.07 | – | 1,015 | 49.00 | 1.50 | 29 | 21 |
| 2025: Q3 | 0.02 | – | 994 | 43.50 | 0.40 | 145 | 161 |
| 2025: Q4 | -0.05 | – | 1,013 | 44.40 | -1.10 | -50 | -67 |
| 2026: Q1 | 0.05 | – | 1,235 | 33.30 | 0.90 | 129 | 121 |
| 2026: Q2 | 0.17 | 142.90 | 1,336 | 31.50 | 2.70 | -17 | -27 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Alignment Healthcare, Inc. betreibt eine verbraucherorientierte Gesundheitsplattform für Senioren in den USA.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 1,849 |
| Headquarters | Orange, CA |
| Website | alignmenthealth.com |
| IPO Date | 26. Mar 2021 |
Management
| Name | Title | Birth Year |
|---|---|---|
| John E. Kao | Founder, Chairman & CEO | 1962 |
| Joseph Samuel Konowiecki J.D. | Vice Chairman & Executive VP of Corporate Affairs | 1954 |
| Dawn Christine Maroney | President | 1968 |
| James M. Head | Chief Financial Officer | 1966 |
| Christopher J. Joyce J.D. | Chief Legal & Administrative Officer | 1964 |
| Hyong J. Kim M.D. | Chief Medical Officer | 1970 |
| Donald S. Furman M.B.A., M.D. | Co-Founder & Chief Clinical Officer | 1951 |
| Shane Hochradel | Chief Operations Officer | – |
| Robert L. Scavo | Chief Information Officer | 1965 |
| Andreas Wagner | Chief Human Resources Officer | 1970 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Maroney Dawn Christine | President | Sell | 177,068 | 20.83 | 3,687,990 |
| 15. Jul 2026 | Maroney Dawn Christine | President | Other | 152,068 | 9.06 | 1,377,736 |
| 10. Jul 2026 | Kao John E | Chief Executive Officer | Sell | 18,356 | 20.65 | 378,998 |
| 10. Jul 2026 | Kao John E | Chief Executive Officer | Sell | 279,644 | 19.81 | 5,540,363 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.